Can New Generation GLP-1s Overcome The Adherence Hurdle?
Historically, Patients Have Not Tended To Stay On These Drugs Long-Term
Novo Nordisk’s new generation of GLP-1 products have led to never-before-seen rates of medication-induced weight loss but require a lifelong commitment from patients to maintain these results – a commitment the market may not be able to rely on, since patients have not generally tended to stay on GLP-1 medications long-term.
